References
- Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20(3):370–385.
- Nelson SM, Yates RW, Fleming R. Serum anti-mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles – implications for individualization of therapy. Hum Reprod. 2007;22(9):2414–2421.
- Hudson PL, Dougas I, Donahoe PK, et al. An immunoassay to detect human Müllerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab. 1990;70(1):16–22.
- Josso N, Legeai L, Forest MG, et al. An enzyme linked immunoassay for anti-müllerian hormone: a new tool for the evaluation of testicular function in infants and children. J Clin Endocrinol Metab. 1990;70(1):23–27.
- Ferraretti A, La Marca A, Fauser BC, ESHRE working group on Poor Ovarian Response Definition, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616–1624.
- La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113–130.
- Broer SL, Dólleman M, Opmeer BC, et al. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46–54.
- Iliodromiti S, Nelson SM. Ovarian response biomarkers: physiology and performance. Curr Opin Obstet Gynecol. 2015;27(3):182–186.
- van Helden J, Weiskirchen R. Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assay. Hum Reprod. 2015;30(8):1918–1926.
- Fleming R, Fairbairn C, Gaudoin M. Objective multicentre performance of the automated assays for AMH and estimation of established critical concentrations. Hum Fertil (Camb)). 2018;21(4):269–274.
- Almog B, Shehata F, Suissa S, et al. Age-related normograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril. 2011;95(7):2359–2363.
- Baker VL, Gracia C, Glassner MJ, et al. Multicenter evaluation of the Access AMH antimullerian assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation. Fertil Steril. 2018;110:306–313.
- Grynnerup AG, Løssl K, Pilsgaard F, et al. Prediction of the lower serum anti-Müllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys® AMH assay: a prospective observational study. Reprod BiolEndocrinol. 2019;17(1):11.
- Anckaert E, Denk B, He Y, et al. Evaluation of the Elecsys ® anti-Müllerian hormone assay for the prediction of hyper-response to controlled ovarian stimulation with a gonadotrophin-releasing hormone antagonist protocol. Eur J ObstetGynecol Reprod Biol. 2019;236:133–138.
- Pearson K, Long M, Prasad J, et al. Assessment of the access AMH assay as an automated, high-performance replacement for the AMH Generation II manual ELISA. Reprod Biol Endocrinol. 2016; 14:8.
- Alviggi C, Andersen CY, Buehler K, Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number), et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452–1453.
- Gallot V, Berwanger da Silva AL, Genro V, et al. Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome. Reprod Biomed Online. 2017; 34:598–604.